China-Asia Stocks

[BiotechValues]

LTUS (Lotus Pharmaceuticals) to restate income HIGHER.
News out yesterday, but headline was poorly worded and caused selling. Bottom line, LTUS will be restating income higher than before. Be sure to read the entire release...especially:
"the effect on the financial statements will generally be an increase in intangible assets and total assets, an increase in due to related parties, total current liabilities and total liabilities, as well as a decrease in general and administrative expenses and total operating expenses and increases in our net income and comprehensive income."